N
Patient 1
(B)(4). (B)(6) REPORT DATED ON 23 MAY 2017. ALTHOUGH WE HAVE ESTABLISHED THAT THE DEVICE DID NOT CAUSE OR CONTRIBUTE TO THE EVENT, WE ARE REPORTING IT OUT OF CAUTION TO BE IN COMPLIANCE WITH 21 CFR PART 803 DUE TO THE BLOOD LOSS (ESTIMATED BLOOD LOSS AROUND 750ML) ENCOUNTERED BY THE PATIENT AND 2 PACKED RED BLOOD CELLS TRANSFUSED TO THE PATIENT WAS ADMITTED IN ICU. SINCE WE DO NOT KNOW IF THERE IS ANY END-USER ERROR INVOLVED WITH THE DEVICE, JMS(B)(4) HAD CONDUCTED AN INVESTIGATION AS A PRECAUTION IF THE DEVICE CONTRIBUTED TO THE ADVERSE EVENT. BASED ON OUR RESERVE SAMPLE EVALUATION AND DEVICE HISTORY RECORD OF THE LOT NUMBER PROVIDED BY THE CLINIC, THERE WAS NO ABNORMALITY FOUND. THE PRODUCTS MET THE QA SPECIFICATIONS PRIOR RELEASING IT TO THE MARKET. THERE WAS NO REPORTED OR DETECTED MALFUNCTION ON THE NEEDLE ITSELF. DUE TO UNAVAILABILITY OF ACTUAL SAMPLE INVOLVED IN THE EVENT, WE ARE UNABLE TO VERIFY THE ACTUAL CAUSE OF THE REPORTED CLAIM. ALTHOUGH WE COULD NOT ESTABLISH CAUSAL EFFECT (EITHER USE ERROR OR PRODUCT DEFECT), WE DID DUE DILIGENCE AND INVESTIGATED THE REPORTED LOT, IN AN EFFORT TO FURTHER SUBSTANTIATE THAT THERE IS NO ABNORMALITY OBSERVED IN OUR PRODUCTS. BASED ON THE INFORMATION FROM FACILITY, THE DISLODGMENT OCCURRED HALF WAY THROUGH A FOUR HOUR TREATMENT. THE NURSE REPORTED THAT THERE WAS NO INDICATION OF NEEDLE MALFUNCTION OR DEFECT. THEY SUSPECTED THAT THE VENOUS NEEDLE DISLODGED FROM PATIENT'S ACCESS DUE TO MOVEMENT OF PATIENT. JMS WAS MADE AWARE THAT THE MACHINE INVOLVED IN THE EVENT WAS REPORTED AS MDR TO MANUFACTURER AND/OR FDA, HOWEVER, DUE TO CONFIDENTIAL POLICIES WE CANNOT OBTAIN THOSE REPORTS. CAUSAL ANALYSIS REVEALS THAT THE REPORTED ADVERSE EVENT INCIDENTS COULD BE DUE TO SOME OTHER POSSIBLE FACTORS THAT RESULTS IN THE DISLODGMENT OF THE NEEDLE SET (I) POOR QUALITY OF TAPE / POOR ADHESION STRENGTH OF THE TAPE, (II) GRAVITATIONAL PULL ON THE AVF NEEDLE SET, (III) DISINFECTANT / LOTION / MEDICATION USED ON THE PATIENT, (IV) PATIENT'S PERSPIRATION, (V) PATIENT'S SKIN CONDITION, (VI) CANNULATION ANGLE. JMS WILL CONTINUE TO MAINTAIN GOOD QUALITY OF OUR PRODUCTS AND ENSURE THAT ONLY GOOD QUALITY PRODUCTS ARE DELIVERED TO CUSTOMERS.